These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17562183)

  • 1. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.
    Fischer B; Oviedo-Joekes E; Blanken P; Haasen C; Rehm J; Schechter MT; Strang J; van den Brink W
    J Urban Health; 2007 Jul; 84(4):552-62. PubMed ID: 17562183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Political challenges in randomized controlled trials of heroin-assisted treatment for severe heroin addiction: a Spanish experience.
    Trujols J; Iraurgi I
    Clin Trials; 2009 Dec; 6(6):658-9; author reply 660. PubMed ID: 20015836
    [No Abstract]   [Full Text] [Related]  

  • 3. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review.
    McNair R; Monaghan M; Montgomery P
    Drug Alcohol Depend; 2023 Jun; 247():109869. PubMed ID: 37086659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.
    Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.
    Oviedo-Joekes E; Nosyk B; Marsh DC; Guh D; Brissette S; Gartry C; Krausz M; Anis A; Schechter MT
    Clin Trials; 2009 Jun; 6(3):261-71. PubMed ID: 19528135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England.
    Riley F; Harris M; Poulter HL; Moore HJ; Ahmed D; Towl G; Walker T
    Harm Reduct J; 2023 May; 20(1):66. PubMed ID: 37173697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials.
    Smart R; Reuter P
    Addiction; 2022 Mar; 117(3):518-531. PubMed ID: 34105206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separating politics and scientific research on heroin prescription.
    Wodak AD; Ritter AJ; Watson CR
    Med J Aust; 2002 May; 176(9):449; author reply 450. PubMed ID: 12057002
    [No Abstract]   [Full Text] [Related]  

  • 9. Dutch government backs down on heroin prescription, despite successful trial.
    Lemmens PH
    Addiction; 2003 Mar; 98(3):247-9. PubMed ID: 12603222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy diacetylmorphine (pharmaceutical heroin) for heroin treatment ].
    Demaret I; Lemaître A; Ansseau M
    Rev Med Liege; 2010 Dec; 65(12):681-7. PubMed ID: 21287763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A different road to recovery.
    Jumnoodoo R; McMahon B; Hehir B; Humm C
    Nurs Stand; 2010 Jun 2-8; 24(39):26-7. PubMed ID: 20572550
    [No Abstract]   [Full Text] [Related]  

  • 12. A heroin prescription trial: case studies from Montreal and Vancouver on crime and disorder in the surrounding neighbourhoods.
    Lasnier B; Brochu S; Boyd N; Fischer B
    Int J Drug Policy; 2010 Jan; 21(1):28-35. PubMed ID: 19447025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why we object to NAOMI. Heroin maintenance in Canada.
    Kahan M; Srivastava A; Shen K
    Can Fam Physician; 2006 Jun; 52(6):705-6, 709-11. PubMed ID: 16812955
    [No Abstract]   [Full Text] [Related]  

  • 14. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial.
    Haasen C; Eiroa-Orosa FJ; Verthein U; Soyka M; Dilg C; Schäfer I; Reimer J
    Alcohol; 2009 Jun; 43(4):259-64. PubMed ID: 19375884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craving and illicit heroin use among patients in heroin-assisted treatment.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two steps forward, one step back: current harm reduction policy and politics in the United States.
    Nadelmann E; LaSalle L
    Harm Reduct J; 2017 Jun; 14(1):37. PubMed ID: 28606093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.
    Klimas J; Dong H; Fairbairn N; Socías E; Barrios R; Wood E; Kerr T; Montaner J; Milloy MJ
    Addict Sci Clin Pract; 2018 Feb; 13(1):3. PubMed ID: 29409539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription of heroin to treatment resistant heroin addicts: heroin handouts are flawed policy.
    Voth EA; Aeschbach E
    BMJ; 2004 Jan; 328(7433):229; author reply 229. PubMed ID: 14739208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.